CXCR2 and neoplasm: Additionally, preclinical studies demonstrate the accumulation of CXCR2+ PMN-MDSCs in the RMS microenvironment and metastatic niches, indicating that these cells are recruited to the TME via chemokines such as CCL2 and CXCL12, where they interact with tumor cells to maintain immunosuppression [56].